按摩与康复医学
按摩與康複醫學
안마여강복의학
Chinese Manipulation & Rehabilitation Medicine
2013年
2期
7-8
,共2页
健脑安神颗粒%失眠症
健腦安神顆粒%失眠癥
건뇌안신과립%실면증
the brain tonic and tranquilization particle%insomnia
目的:观察健脑安神颗粒治疗失眠症的临床疗效.方法:将90例失眠症患者随机分为两组,治疗组予健脑安神颗粒治疗,对照组予艾司唑仑口服.观察比较治疗前后两组临床疗效和匹兹堡睡眠质量指数量表评分、中医证候分级量化积分的变化.结果:用治疗前后匹兹堡睡眠质量指数的变化计算疗效标准,治疗组总有效率为82.22%,对照组总有效率为80.00%,两组疗效比较无显著性差异(P>0.05),中医证候分级量化积分的变化比较,两组治疗后均较治疗前明显下降(P<0.05).结论:健脑安神颗粒治疗失眠症,与艾司唑仑疗效相当,但安全性更高,适合临床推广应用.
目的:觀察健腦安神顆粒治療失眠癥的臨床療效.方法:將90例失眠癥患者隨機分為兩組,治療組予健腦安神顆粒治療,對照組予艾司唑崙口服.觀察比較治療前後兩組臨床療效和匹玆堡睡眠質量指數量錶評分、中醫證候分級量化積分的變化.結果:用治療前後匹玆堡睡眠質量指數的變化計算療效標準,治療組總有效率為82.22%,對照組總有效率為80.00%,兩組療效比較無顯著性差異(P>0.05),中醫證候分級量化積分的變化比較,兩組治療後均較治療前明顯下降(P<0.05).結論:健腦安神顆粒治療失眠癥,與艾司唑崙療效相噹,但安全性更高,適閤臨床推廣應用.
목적:관찰건뇌안신과립치료실면증적림상료효.방법:장90례실면증환자수궤분위량조,치료조여건뇌안신과립치료,대조조여애사서륜구복.관찰비교치료전후량조림상료효화필자보수면질량지수량표평분、중의증후분급양화적분적변화.결과:용치료전후필자보수면질량지수적변화계산료효표준,치료조총유효솔위82.22%,대조조총유효솔위80.00%,량조료효비교무현저성차이(P>0.05),중의증후분급양화적분적변화비교,량조치료후균교치료전명현하강(P<0.05).결론:건뇌안신과립치료실면증,여애사서륜료효상당,단안전성경고,괄합림상추엄응용.
Objective: To observe the efficacy of the brain tonic and tranquilization particle in treatment of insomnia. Methods: 90 patients with insomnia were randomly divided into treatment group and control group. Treatment group were treated by the brain tonic and tranquilization parti-cle, while control group were treated by Estazolam. Observed the clinical effect, the changes of Pittsburgh sleep quality index rating scale and symptom complex classification quantitative integral of TCM. Results:Calculated the criterion of therapeutical effect by the change of Pittsburgh Sleep Quality Index before and after treatment. The total effect rate was 82.22%in treatment group and 80.00%in control group. It had no significant difference between two groups (P>0.05). Compared with the symptom complex classification quantitative integral of TCM, the change was obvious de-scend after treatment (P<0.05). Conclusion:The efficacy of the brain tonic and tranquilization parti-cle corresponds to Estazolam, but the brain tonic and tranquilization particle is more safety, and it is suit to application and dissemination.